-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, OIrWAddSFMpYp5P/YR8XM891xZdyLb6rVK7ccr7tWtB0sMJL8ZLvVf7EZE7lXds6 7jszxT7odCmAnxtYtUGo9A== 0001209191-03-023295.txt : 20030929 0001209191-03-023295.hdr.sgml : 20030929 20030929170922 ACCESSION NUMBER: 0001209191-03-023295 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20030925 FILED AS OF DATE: 20030929 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KIRBY PAMELA J CENTRAL INDEX KEY: 0001189542 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-23520 FILM NUMBER: 03915606 MAIL ADDRESS: STREET 1: 4709 CREEKSTONE DRIVE STREET 2: STE 200 CITY: DURHAM STATE: NC ZIP: 27703 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: QUINTILES TRANSNATIONAL CORP CENTRAL INDEX KEY: 0000919623 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 561714315 STATE OF INCORPORATION: NC FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4709 CREEKSTONE DR STREET 2: RIVERBIRCH BLDG STE 200 CITY: DURHAM STATE: NC ZIP: 27703-8411 BUSINESS PHONE: 9199982000 MAIL ADDRESS: STREET 1: 4709 CREEKSTONE DR STREET 2: STE 300 CITY: DURHAM STATE: NC ZIP: 27703-8411 4 1 doc4.xml FORM 4 SUBMISSION X0201 42003-09-251 0000919623 QUINTILES TRANSNATIONAL CORP QTRN 0001189542 KIRBY PAMELA J 4709 CREEKSTONE DRIVE SUITE 200 DURHAM NC 27703 1100Chief Executive OfficerCommon Stock2003-09-254D0104.22414.5D0Iby QTRN ESOP TrustCommon Stock2003-09-254D076.10514.5D0Iby Spouse in QTRN ESOP TrustCommon Stock2003-09-254D0291814.5D0Iby SpouseStock Option (right to buy)14.93752003-09-254D01000000D 2011-03-12Common Stock10000000DStock Option (right to buy)25.252003-09-254D03126D2011-06-30Common Stock31260DStock Option (right to buy)25.252003-09-254D028415D2011-06-30Common Stock284150DStock Option (right to buy)14.62003-09-254D050746D2011-09-30Common Stock507460DStock Option (right to buy)14.62003-09-254D01914D2011-09-30Common Stock19140Iby SpouseStock Option (right to buy)16.052003-09-254D045416D2011-12-31Common Stock454160DStock Option (right to buy)16.052003-09-254D01713D2011-12-31Common Stock17130Iby SpouseStock Option (right to buy)17.752003-09-254D041163D2012-03-31Common Stock411630DStock Option (right to buy)17.752003-09-254D01552D2012-03-31Common Stock15520Iby SpouseStock Option (right to buy)13.092003-09-254D056137D2012-06-15Common Stock 561370DStock Option (right to buy)13.092003-09-254D04812D2012-06-15Common Stock48120Iby SpouseStock Option (right to buy)9.762003-09-254D078179D2012-09-16Common Stock781790DStock Option (right to buy)9.762003-09-254D06701D2012-09-16Common Stock67010Iby SpouseStock Option (right to buy)12.112003-09-254D062334D2012-12-16Common Stock623340DStock Option (right to buy)12.112003-09-254D05343D2012-12-16Common Stock53430Iby SpouseStock Option (right to buy)12.272003-09-254D062336D2013-03-17Common Stock623360DStock Option (right to buy)12.272003-09-254D05343D2013-03-17Common Stock53430Iby SpouseStock Option (right to buy)14.232003-09-254D055308D2013-06-16Common Stock553080DStock Option (right to buy)14.232003-09-254D04741D2013-06-16Common Stock47410Iby SpouseStock Option (right to buy)14.422003-09-254D052240D2013-09-15Common Stock522400DStock Option (right to buy)14.422003-09-254D04478D2013-09-15Common Stock44780Iby SpouseThe reporting person disclaims beneficial ownership of all securities owned by spouse.Canceled for no consideration pursuant to the Agreement and Plan of Merger, dated April 10, 2003, as amended, by and among Quintiles, Pharma Services Holding, Inc. ("Pharma Services") and Pharma Services Acquisition Corp. (the "Merger Agreement").Disposed of pursuant to the Merger Agreement in exchange for an aggregate cash payment equal to $821,692.16. The cash payment represents the aggregate total paid to the reporting person for all options with an exercise price less than $14.50. The cash payment for each option was derived by taking the excess, if any, of $14.50 over the per share exercise price of such option and multiplying the result by the number of shares of Quintiles common stock subject to each such option./s/ Tammy B. Stogner By: Tammy B. Stogner, Attorney in Fact For: Pamela J. Kirby2003-09-29 -----END PRIVACY-ENHANCED MESSAGE-----